Maybe so mate, I just don't see the same level of excitement coming from the market. So that's all I'm commenting on. I highly value BOT and where it will go both with SB & its pipeline, I'm just saying I don't think FDA approval alone will necessarily see a significant re-rate. I hope I'm wrong - but I tend to think the market is already pricing approval in to a large degree (with perhaps a rise into the 30s following approval). That's just me. But I am also excited about what is to come either through a buyout OR through going to market ourselves and later progressing the pipeline. It's a win/win.
Bot Chart, page-8134
-
- There are more pages in this discussion • 6,736 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $689.3M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 37.5¢ | $1.784M | 4.691M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 248028 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 356327 | 6 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |